|
BKNM-R-07021272
N/A |
|
DSPE-PEG-LLADTTHHRPWT phospholipid-polyethylene glycol-tumor targeting protein
|
￥Member visible
|
|
|
BKNM-R-07021271
N/A |
|
DSPE-PEG-LLADTTHHRPWT phospholipid-polyethylene glycol-tumor targeting protein
|
￥Member visible
|
|
BK2020032601
CAS |
|
MXene sticky water-based ink
|
￥Member visible
|
|
|
BKNM-R-07021270
N/A |
|
DSPE-PEG-LLADTTHHRPWT phospholipid-polyethylene glycol-tumor targeting protein
|
￥Member visible
|
|
|
BK2020050402
CAS |
|
V2C Mxene quantum dots
|
￥Member visible
|
|
|
BKNM-R-07021269
N/A |
|
DSPE-PEG-c-dGHCitGPQ-c phospholipid-polyethylene glycol-tumor targeting protein
|
￥Member visible
|
|
|
BKNM-R-07021268
N/A |
|
DSPE-PEG-VRPMPLQ phospholipid-polyethylene glycol-tumor targeting protein
|
￥Member visible
|
|
|
BK2020050401
CAS |
|
Ti3C2 Mxene quantum dots
|
￥Member visible
|
|
|
BKNM-R-07021267
N/A |
|
DSPE-PEG-LSLERFLRCWSDAPA phospholipid-polyethylene glycol-tumor targeting protein
|
￥Member visible
|
|
|
BKNM-R-07021265
N/A |
|
DSPE-PEG-αCD19 phospholipid-polyethylene glycol-tumor targeting protein
|
￥Member visible
|
|
|
BKNM-R-07021264
N/A |
|
DSPE-PEG-VTLTYEFAAGPRD phospholipid-polyethylene glycol-tumor targeting protein
|
￥Member visible
|
|
|
BKNM-R-07021263
N/A |
|
DSPE-PEG-Anti-HER2 Fab′ phospholipid-polyethylene glycol-tumor targeting protein
|
￥Member visible
|
|
|
BKNM-R-07021262
N/A |
|
DSPE-PEG-αCD20mAb phospholipid-polyethylene glycol-tumor targeting protein
|
￥Member visible
|
|
|
BK2020071007
CAS |
|
Ti2C Mxene quantum dots
|
￥Member visible
|
|
|
BKNM-R-07021261
N/A |
|
DSPE-PEG-Anti-rat CC531mAb phospholipid-polyethylene glycol-tumor targeting protein
|
￥Member visible
|
|
|
BKNM-R-07021258
N/A |
|
DSPE-PEG-Fab’of C225 mAb(cetuximab) phospholipid-polyethylene glycol-tumor targeting protein
|
￥Member visible
|
|
|
BKNM-R-07021256
N/A |
|
DSPE-PEG-mAb 2C5 phospholipid-polyethylene glycol-tumor targeting protein
|
￥Member visible
|
|
|
BKNM-R-07021255
N/A |
|
DSPE-PEG-scFv(HD37-CCH) phospholipid-polyethylene glycol-tumor targeting protein
|
￥Member visible
|
|
|
BKNM-R-07021253
N/A |
|
DSPE-PEG-HD37Fab′ phospholipid-polyethylene glycol-tumor targeting protein
|
￥Member visible
|
|
|
BKNM-R-07021254
N/A |
|
DSPE-PEG-CD19 mAb HD37 phospholipid-polyethylene glycol-tumor targeting protein
|
￥Member visible
|
|
|
BKNM-R-07021252
N/A |
|
DSPE-PEG-rituximab phospholipid-polyethylene glycol-tumor targeting protein
|
￥Member visible
|
|
|
BKNM-R-07021251
N/A |
|
DSPE-PEG-OX26 mAb phospholipid-polyethylene glycol-tumor targeting protein
|
￥Member visible
|
|
|
BKNM-R-07021250
N/A |
|
DSPE-PEG-Anti-CD19 mAb phospholipid-polyethylene glycol-tumor targeting protein
|
￥Member visible
|
|
|
BKNM-R-07021249
N/A |
|
DSPE-PEG-Anti-ErbB2 scFv phospholipid-polyethylene glycol-tumor targeting protein
|
￥Member visible
|
|
|
BKNM-R-07021248
N/A |
|
DSPE-PEG-Anti-CD20 mAb phospholipid-polyethylene glycol-tumor targeting protein
|
￥Member visible
|
|
|
BKNM-R-07021247
N/A |
|
DSPE-PEG-Antinucleosome mAb 2C5 phospholipid-polyethylene glycol-tumor targeting protein
|
￥Member visible
|
|
|
BK2020083104
CAS |
|
Mo2C Mxene quantum dots
|
￥Member visible
|
|
|
BKNM-R-07021246
N/A |
|
DSPE-PEG-Anti-CD44 phospholipid-polyethylene glycol-tumor targeting protein
|
￥Member visible
|
|
|
BKNM-R-07021244
N/A |
|
DSPE-PEG-anti-CD37 mAb phospholipid-polyethylene glycol-tumor targeting protein
|
￥Member visible
|
|
|
BKNM-R-07021243
N/A |
|
DSPE-PEG-YEQDPWGVKWWY phospholipid-polyethylene glycol-tumor targeting protein
|
￥Member visible
|
|
|
BKNM-R-07021242
N/A |
|
DSPE-PEG-Anti-ErbB2 scFv phospholipid-polyethylene glycol-tumor targeting protein
|
￥Member visible
|
|
|
BKNM-R-07021241
N/A |
|
DSPE-PEG-rhuMAb HER2-Fab’or scFv phospholipid-polyethylene glycol-tumor targeting protein
|
￥Member visible
|
